SLS has been in the news 450% more than usual
Jan 02, 2026, 1:32 PM
14.99%
What does SLS do
SELLAS Life Sciences Group, a clinical stage biopharmaceutical company based in New York, develops immunotherapeutics for cancer, including galinpepimut-S and SLS009. The company went public in 2008 and employs 16 staff.
SLS has been in the news recently: SELLAS Life Sciences Group, along with other U.S. stocks, faced a decline as the Dow Jones index fell over 100 points. While FuelCell Energy, Inc. experienced a drop in shares due to an amended stock offering, other companies reported a 25% increase in profits for Q3, indicating strong market performance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.